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ThepresenceofhistoneH3lysine36methylation(H3K36me)
correlates with actively transcribed genes. In yeast, histone
H3K36me mediated by KMT3 (also known as Set2) recruits a
histone deacetylase complex, Rpd3s, to ensure the fidelity of
transcription initiation. We report the purification of human
KMT3a (also known as HYPB or hSet2) complex and the iden-
tification of a novel, higher eukaryotic specific subunit, hetero-
geneousnuclearribonucleoproteinL(HnRNP-L).Interestingly,
although KMT3a has intrinsic activity in vitro, HnRNP-L is
essential in vivo. Moreover, KMT3a generates mono-, di-, and
trimethylated products in vitro, but RNA interference against
KMT3a or HnRNP-L down-regulates exclusively the H3K36me3
mark in vivo.
Inthelasttwodecades,histonemodificationshavebeenrec-
ognized as being pivotal to nearly all DNA templated processes
in eukaryotes (for reviews, see Refs. 1–5). Eukaryotic transcrip-
tionishighlyinfluencedbyvarioushistonemodificationevents.
Besides the well studied marks of histone acetylation, several
histone marks have been linked to active transcription: mono-
ubiquitination of histone H2BK123 (Lys-120 in vertebrates)
and methylation of histones H3K4, H3K36, and H3K79 (for
reviews, see Refs. 6–9).
YeastKMT3,thefirstenzymeidentifiedasmediatingH3K36
methylation(10),islinkedtotranscriptionelongationviaitsinter-
actionwiththeSer-2-phosphorylatedC-terminaldomainofRNA
polymerase II (11–14) through its C-terminal SRI domain (15).
KMT3-mediated H3K36 methylation (H3K36me)
4 serves as a
docking site to recruit a histone deacetylase complex, Rpd3s,
whichinturndeacetylatesthenucleosomesresidingatthecoding
regions to ensure the fidelity of transcription initiation (16–19).
On the other hand, H3K36 methylation can also recruit the
NuA3histoneacetyltransferasecomplexthroughitsPhDfinger
domain-containingsubunitNto1(20,21).Themeansbywhich
H3K36me-mediated recruitment of histone deacetylase and
histone acetyltransferase activities is balanced remains an
interesting question. However, NuA3 interacts with the Set1
methyltransferase, and NuA3 function depends on both Set1
anditssubstrateH3K4(20).Thereforeapossibilityisthatthese
histone deacetylase and histone acetyltransferase complexes
are differentially recruited depending on the co-presence of
H3K4me and H3K36me within the same or neighboring
nucleosomes.
In higher eukaryotes, H3K36 methylation is also linked with
active transcription (22–24). Interestingly, reduced levels of
H3K36 methylation lead to subsequent reductions in H4K16
acetylation(23),whichfurtherimpactsdosagecompensationin
Drosophila (25). In mammals, methylation of H3K36 is also
mediated by the NSD family of enzymes (26),
5 and NSD family
HKMTs share high sequence similarity with yeast KMT3 only
at the Set domain, but not other regions. In contrast, KMT3a
(alsoknownasHYPBorhSet2)isthemammalianorthologueof
yeast KMT3, which shares high sequence similarity with yeast
KMT3a at the Set domain, as well as at the WW and SRI
domains. KMT3a specifically methylates H3K36 (27). Interest-
ingly, unlike the yeast KMT3, knockdown of KMT3a results in
the reduction of H3K36me3 exclusively, without affecting the
other H3K36 methylation states (me1 and me2) in mammals
(28) as well as in Drosophila (23).
Here we report the purification of human KMT3a complex
andtheidentificationofanovel,highereukaryoticspecificsub-
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Supplemental Material can be found at: unit, heterogeneous nuclear ribonucleoprotein L (HnRNP-L).
Interestingly, although KMT3a has intrinsic activity in vitro,
RNAiagainstHnRNP-LleadstothereductionofH3K36me3in
vivo, without affecting KMT3a expression levels.
HnRNP-L is a member of a large family of RRM domain-
containing RNA-binding proteins. It has been implicated in
variousRNA-relatedprocesses,particularlyinmediatingselec-
tive exon inclusion during alternative splicing (29–32) and
facilitating polyadenylation (32, 33). These so-called “post-
transcriptional” events are known to be “co-transcriptional”
(34, 35) and occur proximal to the chromatin templates. Our
finding that HnRNP-L plays a role in regulating chromatin
modification suggests the existence of an elaborative cross-talk
between the chromatin template and co-transcriptional
pre-mRNA processing.
EXPERIMENTAL PROCEDURES
Antibodies—Antibodies against modified histones were pur-
chased from Millipore. Antibody against H3 was kindly pro-
vided by Dr. Xingwang Deng, from the National Institute of
BiologicalSciences,Beijing.Thisantibodyisarabbitpolyclonal
generated with recombinant full-length H3 as immunogen,
which recognize H3 regardless of its modification status. Anti-
body against HnRNP-L was a kind gift from Dr. Gideon Drey-
fuss from the Howard Hughes Medical Institute, Dept. of Bio-
chemistryandBiophysics,UniversityofPennsylvaniaSchoolof
Medicine, Philadelphia.
StableCellLines—pFLAG-KMT3a-CandpFLAG-HnRNP-L
were stably transfected into HEK293 cells to generate the
FLAG-KMT3a-CandFLAG-HnRNP-Lstablecelllines,respec-
tively. Both plasmids were based on pCMV4-FLAG from
Sigma, with a FLAG tag fused at the N terminus, under the
control of CMV promoter.
Affinity Purification of the Human KMT3a Complex—M2
anti-FLAG-agarose (Sigma) was equilibrated with the same
bufferusedinnuclearextractpreparation(20mMTris-HCl(pH
7.9),1.5mMMgCl2,0.42 MNaCl,and0.2mMphenylmethylsul-
fonyl fluoride) and then incubated overnight at 4 °C with
nuclear extract derived from the stable cell lines. The resin was
washed with excess amounts of buffer containing 20 mM Tris-
HCl(pH7.9),1.5mMMgCl2,0.2mMphenylmethylsulfonylflu-
oride, 0.5 M KCl, and proteins eluted with the same buffer sup-
plemented with 0.1 mg/ml FLAG peptide.
Anti-FLAG affinity-purified materials were further fraction-
ated on a 2.4-ml Superose 6 gel filtration column at 4 °C, with
buffer containing 20 mM Tris-HCl (pH 7.9), 0.2 mM phenyl-
methylsulfonyl fluoride, and 0.5 M KCl.
Protein Identification—Gel-resolved proteins were digested
with trypsin and fractionated, and resulting peptide pools were
analyzed by matrix-assisted laser-desorption/ionization
(MALDI) reflectron time-of-flight (TOF) MS. Mass spectro-
metric sequencing of selected peptides was done by MALDI-
TOF/TOF (MS/MS) analysis on the same prepared samples.
Anyidentificationthusobtainedwasverifiedbycomparingthe
computer-generated fragment ion series of the predicted tryp-
tic peptide with the experimental MS/MS data.
RNase Treatment and Co-immunoprecipitation—200 go f
nuclear extracts derived from HEK293 cells stably expressing
FLAG-KMT3a-Cwereincubatedwithexcessamounts(100g)
of RNaseA at 37 °C for 2 h. The extracts were then subjected to
co-immunoprecipitation using antibody against HnRNP-L in
parallel with its mock treated control extracts.
Co-immunoprecipitation between KMT3a and HnRNP-L was
performedunderstringentconditionsbywashingwithbuffercon-
taining 20 mM Tris-HCl (pH 7.9), 1.5 mM MgCl2, 0.2 mM phenyl-
methylsulfonyl fluoride, 0.5 MKCl, and 0.1% Nonidet P-40.
HKMT Assay—A 30 l of reaction mixture containing
S-[methyl-
3H]adenosylmethionine (PerkinElmer Life Sciences),
recombinant oligonucleosomes and enzymes in HKMT assay
buffer (50 mM Tris, pH 8.5, 20 mM KCl, 10 mM MgCl2,1 0m M
dithiothreitol, and 250 mM sucrose) was incubated for1ha t
30 °C. The reaction products were separated by 13% SDS-
PAGE and then subjected to autoradiography.
RNAi Knockdown of KMT3a and HnRNP-L—HeLa cells
treated with HnRNP-L siRNA were analyzed 72 h after trans-
fection. The sequences of chemically synthesized siRNA for
HnRNP-L transient knockdown experiments were adopted
from Hung et al. (32). The upper strand sequences were as
follows: HnRNP-L, 1) 5-GAAUGGAGUUCAGGCGAUGTT-
3;2 )5 -CUACGAUGACCCGCACAAATT-3; and Scram-
bled, 5-UUCUCCGAACGUGUCACGUTT-3. Lentivirus
short hairpin RNA vectors for establishing stable RNAi cell
lines for KMT3a were purchased from Sigma.
Immunofluorescence—Immunofluorescence were performed
with HEK293 cells transiently transfected with siRNA against
HnRNP-L (pair 1). Cells were stained 72 h after transfection.
RESULTS
HnRNP-L Is a Higher Eukaryotic Specific Subunit of Human
KMT3a Complex—Yeast KMT3 interacts with RNA polymer-
ase II (11–14), and its purification under stringent conditions
did not reveal any other co-purifying species present stoichio-
metrically (10). Given our previous experiences with protein
complexes in higher eukaryotes and their complexity in that
they often differ from their yeast counterparts (36, 37), we
attempted to purify the human KMT3a complex to address its
function in mammals.
The closest homologue of yeast KMT3 in Homo sapiens is
KMT3a, which has highly conserved domains and additional
sequences of unknown function (Fig. 1A). Due to the failure of
multiple attempts to stably express tagged full-length KMT3a
in mammalian cells, we established an HEK293 stable cell line
that expresses a FLAG-tagged version of the C-terminal half of
KMT3a (FLAG-KMT3a-C, Fig. 1A). Nuclear extracts derived
from this stable cell line were subjected to affinity purification
using M2 anti-FLAG resin under stringent conditions (for
details see “Experimental Procedures”), followed by Superose 6
gel filtration. Interestingly, FLAG-KMT3a-C co-eluted with a
60-kDa protein forming a complex with an apparent mass of
300kDa.MALDI-TOFmassspectrometryanalysisidentified
the co-eluting protein as HnRNP-L (Fig. 1B). HnRNP-L is an
RNA-binding protein with three RNA recognition motifs,
therefore it was possible that the apparent association between
KMT3a and HnRNP-L was indirect, being mediated by their
co-binding an RNA molecule. However, treatment of the
nuclear extracts with excess amounts of RNaseA at 37 °C prior
H3K36TrimethylationRequiresKMT3aSubunitHnRNP-L
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 to affinity purification did not abolish the association between
KMT3a and HnRNP-L (Fig. 1C), indicating the association is
likely due to direct protein-protein interaction.
To further scrutinize the above finding as well as to obtain a
complexcontainingfull-lengthKMT3a,weestablishedastable
celllineexpressingFLAG-taggedHnRNP-L.Reciprocalaffinity
purification with nuclear exacts from these cells indeed co-pu-
rified the endogenous full-length KMT3a (Fig. 1D), which was
confirmed by Western blot (data not shown, see also Fig. 1E)
and HKMT activity assays (see Fig. 3, A and B).
We next performed co-immunoprecipitation experiments
usingHeLacellnuclearextractsandantibodiesagainstKMT3a
and HnRNP-L to test for their interaction under endogenous
conditions. Antibodies against KMT3a co-immunoprecipi-
tated the endogenous HnRNP-L (Fig. 1E, lower panel). In a
reciprocal experiment, antibodies against HnRNP-L co-immu-
noprecipitated the endogenous
KMT3a (Fig. 1E, upper panel). In
control experiments, antibody
againstHAwasineffectual(Fig.1E).
Interaction Domain Mapping—
To map the regions of KMT3a
responsible for its interaction with
HnRNP-L, several GST-tagged
KMT3a deletion mutants (Fig. 2A,
left panel) were expressed and puri-
fied from Escherichia coli (Fig. 2A,
middle panel), then incubated with
recombinant His-tagged HnRNP-L
purified from E. coli, and sub-
jected to the nickel-agarose pull-
down assay. Silver staining of the
eluates demonstrated that two
regions of KMT3a could interact
with HnRNP-L independently. One
region encompasses the linker
sequence between the WW domain
and the SET domain, and another
region consists of the SRI domain
(Fig. 2A, right panel). Nickel-agar-
ose alone did not pull down any of
the deletion mutants in control
experiments (data not shown). In
addition, the KMT3a SET domain
failed to interact with HnRNP-L
(Fig. 2A, right panel).
To map the domains on
HnRNP-L responsible for its inter-
action with KMT3a, several His-
tagged HnRNP-L deletion mutants
(Fig. 2B, left panel) were expressed
and purified from E. coli, then incu-
bated with the recombinant GST-
tagged KMT3a deletion mutants
and subjected to the nickel-agarose
pulldown assay. Silver staining of
the eluates demonstrated that two
regions of KMT3a could interact
with HnRNP-L independently. The region containing the first
RRM domain of HnRNP-L was sufficient to interact with the
most C-terminal part of KMT3a (deletion K4) (Fig. 2B, bottom
of right panel), whereas the region encompassing the second
RRM domain could stabilize the interaction by binding to the
KMT3a linker sequence between the SET and WW domains
(Fig. 2B, top and middle of right panel). These studies collec-
tively demonstrate the domains of each protein require for
interaction, and further reinforce our purification studies.
None of the interactions described above were sensitive to
RNase treatment (data not shown).
Substrate and Reaction Specificity of Human KMT3a
Complex—We then performed the histone methyltransferase
assayusingthehumanKMT3acomplexpurifiedfromHEK293
cells stably expressing FLAG-HnRNP-L. The results showed it
to be a nucleosomal specific HKMT, exhibiting barely detecta-
FIGURE1.HnRNP-LisanovelsubunitofthehumanKMT3acomplex.A,domainstructureofhumanKMT3a
and yeast KMT3. B, silver staining indicates co-elution of HnRNP-L with FLAG -KMT3a-C. Fractions were from a
2-mlSmartSuperose6gelfiltrationcolumn.Theinputofthiscolumnisaffinity-purifiedKMT3afromcellsstably
expressingFLAG-KMT3a-C.Fractionnumbersareshownatthetopofthepanel.C,interactionbetweenKMT3a
and HnRNP-L is independent of RNase treatment. D, endogenous, full-length KMT3a co-purifies with FLAG-
HnRNP-LinnuclearextractsfromstablecellsexpressingFLAG-HnRNP-L.E,reciprocalco-immunoprecipitation
experiments demonstrate interactions between endogenous KMT3a and HnRNP-L in HeLa cells.
H3K36TrimethylationRequiresKMT3aSubunitHnRNP-L
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 ble activity on core histones (Fig. 3A). In addition, its activity
was specific for H3K36, because the K36A substitution
mutant was completely defective as a substrate, while other
K3A substitution mutants of histone H3 were successfully
methylated (Fig. 3B). This result is consistent with that
reported for the substrate specificity of the recombinant
KMT3a SET domain (27).
Mass spectrometric analysis of the products formed in the in
vitro HKMT assay demonstrated that KMT3a is capable of meth-
ylating H3K36 to mono-, di-, and trimethylated status (Fig. 3C).
This is in contrast to that observed in vivo. RNAi against KMT3a
exclusivelyreducedtheH3K36me3markinvivo,withoutaffecting
the mono- and dimethylated status either in mammals (supple-
mental Fig. S1) (28) or in Drosophila (23).
TheLevelofHistoneH3K36me3IsDependentonKMT3aand
HnRNP-L in Vivo—To further understand the functional
importance of the KMT3a complex in vivo, especially with
regard to its newly identified HnRNP-L subunit, we investi-
gated the levels of various histone modifications in cells after
HnRNP-L knockdown. Two different siRNA pairs successfully
achieved HnRNP-L knockdown in HeLa cells (Fig. 4). Nuclear
lysates were then analyzed by Western blot using various anti-
bodies against histone proteins and specific histone modifica-
tions. In cells treated with either of the HnRNP-L siRNA pairs,
we observed significantly lower H3K36me3 levels, but no
apparent change in the levels of H3K36me1/2 or the other
modifications tested (Fig. 4).
To validate these results, we also performed immunofluo-
rescence studies using HEK293 cells transiently transfected
with siRNA targeting HnRNP-L and co-staining with anti-
bodies against HnRNP-L and either histone H3 or modified
histone H3. Fig. 5 demonstrates the essential role of
HnRNP-L in maintaining H3K36me3 levels in vivo. Consist-
ent with the Western results shown in Fig. 4, none of the
FIGURE2.Interactiondomainmapping.A,left,schematicrepresentationofGST-taggedKMT3adeletionmutantsusedfortheinteractionassay.Middle,silver
stain of purified recombinant GST-KMT3a deletion mutants. Right, results from the nickel agarose pulldown assay using His-HnRNP-L. B, left, schematic
representation of His-tagged HnRNP-L deletion mutants. Right, results from nickel pulldown assays using deletion mutants of His-tagged HnRNP-L and of
GST-KMT3a, as indicated.
H3K36TrimethylationRequiresKMT3aSubunitHnRNP-L
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 other modifications tested, including H3K36me1/2, were
affected.
HnRNP-L Does Not Stimulate KMT3a Activity in Vitro—Be-
cause HnRNP-L knockdown had the same effect on histone
H3K36 trimethylation as previously reported for KMT3a
knockdown (supplemental Fig. S1) (28), we next examined if
HnRNP-L could stimulate the HKMT activity of KMT3a bio-
chemically. To address this, reconstitution experiments were
performed using recombinant KMT3a-C and HnRNP-L,
expressed from baculovirus independently or together. Co-ex-
pression of the two recombinant proteins displayed similar
activity as KMT3a-C alone. In addition, titrating in recombi-
nantHnRNP-LwasineffectualwithrespecttoKMT3a-Cactiv-
ity (Fig. 6). Thus, HnRNP-L does not appear to up-regulate
KMT3a activity under these conditions. Similar results were
observed in the presence of synthetic RNA (data not shown).
DISCUSSION
In this report, we presented the isolation, biochemical char-
acterization, and functional analysis of the human KMT3a
complex,whichiscomposedofKMT3aandahighereukaryotic
specific subunit HnRNP-L. Although KMT3a has intrinsic
activity in vitro (27) (Figs. 3 and 6), HnRNP-L is required for its
activity in vivo (Figs. 4 and 5). Moreover, KMT3a generates
mono-, di-, and trimethylated products in vitro (Fig. 3C), but
RNAi against KMT3a (supplemental Fig. S1) (23, 28) or
HnRNP-L (Figs. 4 and 5) down-regulates exclusively the
H3K36me3 mark in vivo, suggesting other H3K36-specific
HKMTs might be responsible for H3K36 mono- and dimeth-
ylation in vivo. Indeed our unpublished studies demonstrate
that NSD1, NSD2, and NSD3 dimethylates H3K36.
5
How Does HnRNP-L Contribute to the HKMT Activity of
KMT3a?—The exact mechanism by which HnRNP-L contrib-
utestotheHKMTactivityofKMT3aispresentlyanopenques-
tion. One possibility is that HnRNP-L plays a role in targeting
the KMT3a complex to certain regions in chromatin. This is
plausible given that HnRNP-L is an RNA-binding protein with
certainsequencecontextpreferences(29,38).Itisanintriguing
possibility that selective binding toward certain RNA
sequences could enrich the local concentration of the KMT3a
complex at particular chromatin region(s), giving rise to hot
spots of H3K36me3. Because HnRNP-L is a higher eukaryotic
specific subunit of the KMT3a complex, such H3K36me3 hot
spots are unlikely to exist in yeast. Additional high resolution
chromatin immunoprecipitation experiments in higher
eukaryotes might be necessary to prove or disprove the exist-
ence of such hot spots. Another intriguing possibility is that
HnRNP-LmaybindtothenascentRNA,thusdirectingKMT3a
to establish the H3K36me3 mark on the template chromatin,
which might in turn recruit factors involved in co-transcrip-
tional RNA processing (see detailed discussions below).
Are There Any Functions of H3K36me3 Specific to Higher
Eukaryotes?—That higher eukaryotes express a subunit that
specifically regulates HKMT trimethylase activity toward
H3K36 begs the question of whether there are higher eukary-
otic specific functions of H3K36me3 yet to be appreciated.
BecauseHnRNP-LisanRNA-bindingproteininvolvedinmul-
tiple pre-mRNA processing events (29–33), if there are higher
eukaryotic specific functions of H3K36me3, they are likely
linked to co-transcriptional pre-mRNA processing such as
splicing (or alternative splicing) and polyadenylation.
Splicing is largely a higher eukaryotic specific event, because
most yeast genes do not have intron(s). In contrast, human
exons are often dispersed and spaced apart by huge introns.
Although multiple mechanisms (for reviews, see Refs. 39, 40)
exist for correctly selecting these small exons out of the bulky
FIGURE 3. KMT3a HKMT activity. A, KMT3a complex purified from HEK293
cells stably expressing FLAG-HnRNP-L is a nucleosomal HKMT that does not
use core histones as substrates. B, KMT3a complex is specific for H3K36.
C,massspectrometricanalysisshowingthatKMT3ahasmono-,di-,andtrim-
ethylation activities in vitro.
FIGURE4.RNAiagainstHnRNP-Ldown-regulatesH3K36me3levels.West-
ern analysis showing specific reduction in HnRNP-L and H3K36me3 levels in
HeLa cells treated with two different siRNA pairs against HnRNP-L. A pair of
siRNA with scrambled sequences was used as control.
H3K36TrimethylationRequiresKMT3aSubunitHnRNP-L
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 introns, it is certainly possible that other regulatory mecha-
nisms are involved. One attractive hypothesis is that the chro-
matintemplatesofexonsinmost,oralternativelysplicedgenes
are marked by specific histone modification(s) that recruit the
splicing machinery thereby elevating its local concentration to
the sites of the splicing substrates. Of note, H3K4me3, a mark
for the start site of transcription, could recruit CHD1 that in
turn recruits U2 and stimulates the rate of splicing in vivo (41).
However, as of now, chromatin
modification(s) specifically marking
the exons or exon-intron junctions
have not been reported. Yet
H3K36me3 would be a good candi-
date in this scenario as HnRNP-L is a
factor involved in alternative splicing
(29–32) and, as shown here, is also a
subunit of a chromatin-modifying
enzyme complex essential for its
activity. In support of this hypothesis
thatthesplicingmachinerycouldrec-
ognize the H3K36me3 mark, a recent
reportdemonstratedthatH3K36me3
is specifically enriched at the intron-
exon boundaries (42).
Anotherpost-transcriptionalproc-
ess to be considered is polyadenyl-
ation. Polyadenylation sites consist of
a highly conserved sequence motif
AAUAAAonthepre-mRNA(43,44).
Such a sequence could occur once
every 4096 bp by chance. Although
this is unlikely to be an issue in the case of yeast, it could pose a
huge challenge to the integrity of polyadenylation in mammals
that often produce pre-mRNA products of over 200 kb, each
potentiallycontainingover50suchAAUAAAmotifs.Thushigher
eukaryotes might require additional mechanisms to ensure cor-
rect transcription termination and polyadenylation. This might
entail that a gene, encoding a nascent mRNA that has been suc-
cessfully cleaved by the polyadenylation machinery, would be
markedwithcertainhistonemodification(s)tofacilitatetranscrip-
tion termination. Of note, a histone modification (H3K4me3)
marking the transcription start site (45, 46) has been reported to
recruit RNA polymerase II general transcription factor D (TFIID)
(47). In this case, productive transcription sets the mark at the
initiation site, which in turn stabilizes the recruited transcription
machinery, safeguarding the proper initiation of subsequent tran-
scription. H3K36me3 serves as an interesting candidate to mark
the termination site not only because it has a higher eukaryotic-
specific regulator, but also its levels tend to peak at the 3-end of
genes (22).
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